TY - JOUR
T1 - Frequency of premature menopause in women who carry a BRCA1 or BRCA2 mutation
AU - Finch, Amy
AU - Valentini, Adriana
AU - Greenblatt, Ellen
AU - Lynch, Henry T.
AU - Ghadirian, Parviz
AU - Armel, Susan
AU - Neuhausen, Susan L.
AU - Kim-Sing, Charmaine
AU - Tung, Nadine
AU - Karlan, Beth
AU - Foulkes, William D.
AU - Sun, Ping
AU - Narod, Steven
N1 - Funding Information:
Amy Finch acknowledges the support of the Ontario Postdoctoral Fellowship through the Ontario Ministry of Research and Innovation and Women’s College Hospital . Susan L. Neuhausen is partially supported by the Morris and Horowitz Families Endowed Professorship .
PY - 2013/5
Y1 - 2013/5
N2 - Objective: To evaluate the impact of carrying a BRCA1 or BRCA2 mutation on the probability of experiencing premature natural menopause. Design: Observational study. Setting: Patients in an academic research environment. Patient(s): Women who carry a BRCA1 or BRCA2 mutation (case subjects) and women who do not carry a mutation (control subjects). Intervention(s): Survey about reproductive history administered on study entry and every 2 years thereafter. Main Outcome Measure(s): The impact of carrying a BRCA mutation on age at menopause and other factors, including parity, age at first birth, age at last birth, and self-reported fertility. Result(s): A total of 908 matched pairs were identified. The mean age at natural menopause was 48.8 years for BRCA1 carriers, 49.2 years for BRCA2 carriers, and 50.3 years for control subjects. Women who carried a BRCA mutation had parity similar to noncarriers and were as likely as noncarriers to have a child after age 35 years. Similar proportions reported a history of fertility problems (12.5% vs. 13.7%) and use of fertility medication (6.0% vs. 7.0%). Conclusion(s): Women who carry a BRCA mutation experience menopause earlier, on average, than women who do not have a mutation, but the difference is small and does not appear to affect fertility.
AB - Objective: To evaluate the impact of carrying a BRCA1 or BRCA2 mutation on the probability of experiencing premature natural menopause. Design: Observational study. Setting: Patients in an academic research environment. Patient(s): Women who carry a BRCA1 or BRCA2 mutation (case subjects) and women who do not carry a mutation (control subjects). Intervention(s): Survey about reproductive history administered on study entry and every 2 years thereafter. Main Outcome Measure(s): The impact of carrying a BRCA mutation on age at menopause and other factors, including parity, age at first birth, age at last birth, and self-reported fertility. Result(s): A total of 908 matched pairs were identified. The mean age at natural menopause was 48.8 years for BRCA1 carriers, 49.2 years for BRCA2 carriers, and 50.3 years for control subjects. Women who carried a BRCA mutation had parity similar to noncarriers and were as likely as noncarriers to have a child after age 35 years. Similar proportions reported a history of fertility problems (12.5% vs. 13.7%) and use of fertility medication (6.0% vs. 7.0%). Conclusion(s): Women who carry a BRCA mutation experience menopause earlier, on average, than women who do not have a mutation, but the difference is small and does not appear to affect fertility.
UR - http://www.scopus.com/inward/record.url?scp=84876974335&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84876974335&partnerID=8YFLogxK
U2 - 10.1016/j.fertnstert.2013.01.109
DO - 10.1016/j.fertnstert.2013.01.109
M3 - Article
C2 - 23414920
AN - SCOPUS:84876974335
VL - 99
SP - 1724
EP - 1728
JO - Fertility and Sterility
JF - Fertility and Sterility
SN - 0015-0282
IS - 6
ER -